Bilogix Implements Enterprise Performance Management Solutions

The chairman of Alpine, New Jersey-based Cambridge Therapeutics, John Klein offers next-generation solutions in areas ranging from combination therapies to drug delivery. Building on his experience with Cambridge Therapeutics, John Klein recently launched Bilogix in Alpine, NJ, a provider of enterprise performance management (EPM) consulting services.

Encompassing processes and applications, the EPM approach is one that transforms key performance indicator (KPI) data into highly accurate ways of analyzing, monitoring, measuring, and forecasting organizational results. It adds value through bringing focus on the details of how strategic plans are envisioned and implemented, as well as how challenges and inconsistencies are addressed when they occur.

This ensures that resources are utilized more efficiently toward defined goals, at both the operational and tactical levels. At the same time, the effects of business intelligence investments can be tracked via a dashboard and real-time scorecards. This puts the power in the hands of those who implement EPM solutions and provides easy-to-visualize output that meets the expectations of executive boards and shareholders.